CervoMed (CRVO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on CervoMed (CRVO) is Neutral.

The composite score behind that read is -0.15, weighing +0.00 of bullish evidence against -0.38 bearish.

CervoMed last closed at $3.28, +3.14% on the session.

Against the IVW growth benchmark the position is +4.37% over the forecast window.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

19 graded predictions for CRVO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks CervoMed in the 7th percentile on return on equity, where 100 is best.

CervoMed is classified under Health Care / Biotechnology, with a market capitalisation of $48.08M.

StockMap tracks CervoMed as the 315th largest of the 380 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 304 Neutral, 65 Moderate Underperform and 11 Moderate Outperform.

On that composite CervoMed ranks 274th of 380 in the group, against a group median of -0.10.